Neurocognitive Outcomes and School Performance in Solid Tumor Cancer Survivors Lacking Therapy to the Central Nervous System

Author： Mohrmann Caroline Henry Jennifer Hauff Marnie Hayashi Robert J.

Publisher： MDPI

E-ISSN： 2075-4426|5|2|83-90

ISSN： 2075-4426

Source： Journal of Personalized Medicine, Vol.5, Iss.2, 2015-04, pp. : 83-90

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The E. coli CNF1 as a Pioneering Therapy for the Central Nervous System Diseases

By Travaglione Sara Loizzo Stefano Ballan Giulia Fiorentini Carla Fabbri Alessia

Toxins, Vol. 6, Iss. 1, 2014-01 ,pp. : 270-282

MDPI

Access to resources Recommend Favorite

Glycosaminoglycans and Glycomimetics in the Central Nervous System

By Rowlands Dáire Sugahara Kazuyuki Kwok Jessica C. F.

Molecules, Vol. 20, Iss. 3, 2015-02 ,pp. : 3527-3548

MDPI

Access to resources Recommend Favorite

Is Ghrelin Synthesized in the Central Nervous System?

By Cabral Agustina López Soto Eduardo J. Epelbaum Jacques Perelló Mario

International Journal of Molecular Sciences, Vol. 18, Iss. 3, 2017-03 ,pp. : 638-638

MDPI

Access to resources Recommend Favorite

Growth Hormone (GH) and Gonadotropin-Releasing Hormone (GnRH) in the Central Nervous System: A Potential Neurological Combinatory Therapy?

By Martínez-Moreno Carlos G. Calderón-Vallejo Denisse Harvey Steve Arámburo Carlos Quintanar José Luis

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-01 ,pp. : 375-375

MDPI

Access to resources Recommend Favorite

Fiber-Modified Adenovirus for Central Nervous System Parkinson’s Disease Gene Therapy

By Lewis Travis B. Glasgow Joel N. Harms Ashley S. Standaert David G. Curiel David T.

Viruses, Vol. 6, Iss. 8, 2014-08 ,pp. : 3293-3310

MDPI

Access to resources Recommend Favorite